IP Verse

Antibodies Against A Proliferating Inducing Ligand (April) - EP3103476

The patent EP3103476 was granted to Aduro Biotech on Jul 27, 2022. The application was originally filed on Feb 23, 2010 under application number EP16075009A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3103476

ADURO BIOTECH
Application Number
EP16075009A
Filing Date
Feb 23, 2010
Status
Granted And Under Opposition
Jun 24, 2022
Grant Date
Jul 27, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ZWICKER SCHNAPPAUF & PARTNERApr 25, 2023WITHDRAWN

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONEP2403528
OPPOSITIONEP3103476
OPPOSITIONWO0160397
OPPOSITIONWO02094192
OPPOSITIONWO2010100056
OPPOSITIONWO2016110587
SEARCHUS2002081296
SEARCHWO0160397
SEARCHWO02094192

Non-Patent Literature (NPL) Citations (34) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Immunoassays", Anonymous, Ed Harlow , David Lane, Antibodies a laboratory manual, Cold Spring Harbor Laboratory Press, (19880101), pages 578 - 583, ISBN 0-87969-314-2, XP093087662-
OPPOSITION- Anonymous, "Recombinant Human BCMA/TNFRSF17 Fc Chimera Protein, CF 193-BC-050: ", R&D Systems catalogue, R&D Systems, (20240429), pages 1 - 7, R&D Systems catalogue, URL: https://www.rndsystems.com/products/recombinant-human-bcma-tnfrsf17-fc-chimera-protein-cf_193-bc, XP093156757-
OPPOSITION- Anonymous, "Recombinant Human TACI/TNFRSF13B Fc Chimera Protein, CF", R&D Systems catalogue, R&D Systems, (20240429), pages 1 - 6, R&D Systems catalogue, URL: https://www.rndsystems.com/products/recombinant-human-taci-tnfrsf13b-fc-chimera-protein-cf_174-tc, XP093156759-
OPPOSITION- Anonymous, "TNFRSF13B; Details For Glycoprotein O14836-1", GlyGen, (20240429), Database accession no. O14836-1, XP093156804-
OPPOSITION- Anonymous, "TNFRSF17; Details For Glycoprotein Q02223-1", GlyGen, (20240429), Database accession no. Q02223-1, XP093156801-
OPPOSITION- Gatto Barbara, "Atacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells", CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, US , (20081101), vol. 9, no. 11, ISSN 1472-4472, pages 1216 - 1227, XP009129571-
OPPOSITION- HB Shu, WH Hu, H Johnson, "TALL-1 is a novel member of the TNF family that is down-regulated by mitogens", Journal of Leukocyte Biology, GB , (19990501), vol. 65., no. 5, doi:10.1002/jlb.65.5.680, ISSN 0741-5400, pages 680 - 683, XP000939092-
OPPOSITION- Jonathan Barratt, "Updated Interim Results of a Phase 1/2 Study of Zigakibart (BION-1301)* in Patients with IgA Nephropathy", 17th International Symposium on IgA Nephropathy; September 28 (Thursday) to 30 (Saturday), 2023; Tokyo, Japan, (20230901), pages 1 - 1, XP093156752-
OPPOSITION- Leonid Gorelik, Kevin Gilbride, Max Dobles, Susan L. Kalled, Daniel Zandman, and Martin L. Scott, "Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant Cells", Journal of Experimental Medicine, (20030000), vol. 198, no. 6, doi:10.1084/jem.20030789, pages 937 - 945-
OPPOSITION- Mary M. Bendig And S.Tarran Jones, "Rodent to human antibodies by CDR grafting", Mary M. Bendig And S.Tarran Jones, McCafferty J; Hoogenboom and D J Chiswell H R, Antibody Engineering: A practical approach, New York, Oxford University Press , (19960101), pages 3pp, 148 - 185, XP055308543-
OPPOSITION- Mason D W, Williams A F, "Kinetics of antibody reactions and the analysis of cell surface antigens", Mason D W, Williams A F, D M Weir, Handbook of Experimental Immunology , Blackwell Science Inc, (19860101), pages 38.1 - 38.17, XP093087683-
OPPOSITION- Ryan M C; Grewal I S, "Targeting of BAFF and APRIL for autoimmunity and oncology", Retinal Degenerative Diseases: Advances inExperimental Medicine and Biolog, US , (20090101), vol. 647, doi:10.1007/978-0-387-89520-8_4, ISBN 978-3-319-72798-1, pages 52 - 63, XP009179268
OPPOSITION- Guigas Gernot; Weiss Matthias, "Effects of protein crowding on membrane systems", Biochimica et Biophysica Acta, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20151224), vol. 1858, no. 10, doi:10.1016/j.bbamem.2015.12.021, ISSN 0005-2736, pages 2441 - 2450, XP029680980
OPPOSITION- Jun Woo Kim et al., "Targeting ligand-receptor interactions for development of cancer therapeutics ", Current Opinion in chemical Biology, (2017), vol. 38, doi:10.1016/j.cbpa.2017.03.010, XP085070187
OPPOSITION- Scot A. Marsters, Minhong Yan, Robert M. Pitti , Philip E. Haas, Vishva M. Dixit ,Avi Ashkenazi, "Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI", Current Biology, GB , (20000629), vol. 10, no. 13, doi:10.1016/S0960-9822(00)00566-2, ISSN 0960-9822, pages 785 - 788, XP000992744
OPPOSITION- Gang Yu, Tom Boone, John Delaney, Nessa Hawkins, Michael Kelley, Meena Ramakrishnan, Susan McCabe, Wan-rong Qiu, Masayo Kornuc, Xing-Zhong Xia, Jane Guo, Marina Stolina, William J. Boyle, Ildiko Sarosi, Hailing Hsu, Giorgio Senaldi , Lars E. Theill, "APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity", Nature Immulogy, New York , (20000901), vol. 1, no. 3, doi:10.1038/79802, ISSN 1529-2908, pages 252 - 256, XP000992743
OPPOSITION- Mikhail B Litinsky , Bernardetta Nardelli , Davind M Hilbert , Bing He , Andras Schaffer , Paolo Casali , Andrea Cerutti, "DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL", Nature Immulogy, New York , (20020901), vol. 3, no. 9, doi:10.1038/ni829, ISSN 1529-2908, pages 822 - 829, XP002419141
OPPOSITION- Perez De La Lastra, Van Den Berg, Bullido, Almazan, Dominguez, Llanes, Morgan, "Epitope mapping of 10 monoclonal antibodies against the pig analogue of human membrane cofactor protein (MCP)", Cancer research, GB , (19990401), vol. 96, no. 4, doi:10.1046/j.1365-2567.1999.00732.x, ISSN 0019-2805, pages 663 - 670, XP055572134
OPPOSITION- Sarah G. Hymowitz, Darshana R. Patel, Heidi J.A. Wallweber, Steven Runyon, Minhong Yan, JianPing Yin, Stephanie K. Shriver, Nathaniel C. Gordon, Borlan Pan, Nicholas J. Skelton, Robert F. Kelley, Melissa A. Starovasnik, "Structures of APRIL-receptor complexes - Like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding", JBC Journal of biological chemistry, (20050000), vol. 280, no. 8, doi:10.1074/jbc.M411714200, pages 7218 - 7227, XP002373779
OPPOSITION- P. Rennert, P. Schneider, T. G. Cachero, J. Thompson, L. Trabach, S. Hertig, N. Holler, F. Qian, C. Mullen, K. Strauch, J. L. Browning, C. Ambrose, J. Tschopp, "A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member April, Inhibits Tumor Cell Growth", Journal of Clinical Oncology, (20001204), vol. 14, no. 3, doi:10.1084/jem.192.11.1677, ISSN 0732-183X, pages 737 - 1684, XP055071428
OPPOSITION- Scapini Patrizia, Nardelli Bernardetta, Nadali Gianpaolo, Calzetti Federica, Pizzolo Giovanni, Montecucco Cesare, Cassatella Marco A., "G-CSF-stimulated Neutrophils Are a Prominent Source of Functional BLyS", Journal of Experimental Medicine, US , (20030203), vol. 197, no. 3, doi:10.1084/jem.20021343, ISSN 0022-1007, pages 297 - 302, XP093087632
OPPOSITION- M López-Fraga R Fernández J P Albar M Hahne, "Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase", EMBO Reports, GB , (20011001), vol. 2, no. 10, doi:10.1093/embo-reports/kve198, ISSN 1469-221X, pages 945 - 951, XP002370450
OPPOSITION- W. Mark Abbott, Melissa M. Damschroder, David C. Lowe, "Current approaches to fine mapping of antigen-antibody interactions", Cancer research, GB , (20140801), vol. 142, no. 4, doi:10.1111/imm.12284, ISSN 0019-2805, pages 526 - 535, XP055681987
OPPOSITION- Paul A Moore , Ornella Belvedre , Amy Orr , Krystyna Pieri , David W LaFleur , Ping Feng , Daniel Soppet , Meghan Charters , Reiner Gentz , David Parmelee , Yuling Li , Olga Galoerina , Judith Giri , Viktor Roschke, Brnardetta Nardelli , Jeffrey Carrell , Svetlana Sosnovtseva , Wilbert Greenfield , Steven M Ruben , Henrik S Olsen , James Fikes , Davind M Hilbert, "BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.", Science, US , (19990709), vol. 285, doi:10.1126/science.285.5425.260, ISSN 0036-8075, pages 260 - 263, XP002142252
OPPOSITION- John Dulos, "Abstract 2645: Development of a first in class APRIL fully blocking antibody BION-1301 for the treatment of multiple myeloma", Cancer research, American Association for Cancer Research, US, US, (20170701), vol. 77, no. Suppl. 13, doi:10.1158/1538-7445.AM2017-2645, ISSN 0008-5472, page 2645, XP093156743
OPPOSITION- Jens V. Stein, Marta López-Fraga, Fernando A. Elustondo, Carla E. Carvalho-Pinto, Dolores Rodríguez, Ruth Gómez-Caro, Joan De Jong, Carlos Martínez-A, Jan Paul Medema, Michael Hahne, "APRIL modulates B and T cell immunity", Journal of Clinical Investigation, (20020615), vol. 109, no. 12, doi:10.1172/JCI200215034, ISSN 00219738, pages 1587 - 1598, XP055187426
OPPOSITION- Moreaux Jérôme, Cremer Friedrich W., Reme Thierry, Raab Marc, Mahtouk Karene, Kaukel Philine, Pantesco Veronique, De Vos John, Jourdan Eric, Jauch Anna, Legouffe Eric, Moos Marion, Fiol Genevieve, Goldschmidt Hartmut, Rossi Jean François, Hose Dirk, Klein Bernard, "The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature", Blood, US , (20050801), vol. 106, no. 3, doi:10.1182/blood-2004-11-4512, ISSN 0006-4971, pages 1021 - 1030, XP093087636
OPPOSITION- Bernadetta Nardelli, "Synthesis and release of B-lymphocyte stimulator from myeloid cells", Blood, (20010101), vol. 97, no. 1, doi:10.1182/blood.V97.1.198, pages 198 - 204, XP055255123
OPPOSITION- Ernst Böhm, Birgit K. Seyfried, Michael Dockal, Michael Graninger, Meinhard Hasslacher, Marianne Neurath, Christian Konetschny, Peter Matthiessen, Artur Mitterer, Friedrich Scheiflinger, "Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells", BMC Biotechnology, BioMed Central Ltd, (20151218), vol. 114, no. Suppl 6, doi:10.1186/s12896-015-0205-1, pages 1 - 15, XP055261334
OPPOSITION- Heddy Zola, "Monoclonal Antibodies A Manual of Techniques", Heddy Zola, Heddy Zola, Using monoclonal antibodies : solube antigens, CRC Press, (19870000), pages 147 - 158, doi:10.1201/9781482242683, XP093087674
OPPOSITION- Tongtong Zhang, "Plasma Membrane Integrates Biophysical and Biochemical Regulation to Trigger Immune Receptor Functions", Frontiers in Immunology, Frontiers Media, Lausanne, CH, Lausanne, CH , (20210219), vol. 12, doi:10.3389/fimmu.2021.613185, ISSN 1664-3224, pages 613185 - 8, XP093156764
SEARCH- CH'EN ET AL, "Characterisation of monoclonal antibodies to the TNF and TNF receptor families", CELLULAR IMMUNOLOGY, ACADEMIC PRESS, SAN DIEGO, CA, US, (20050701), vol. 236, no. 1-2, ISSN 0008-8749, pages 78 - 85, XP005197727 [A] 1-19 * the whole document *
SEARCH- TANGYE S G ET AL, "BAFF, APRIL and human B cell disorders", SEMINARS IN IMMUNOLOGY, W.B. SAUNDERS COMPANY, PA, US, vol. 18, no. 5, ISSN 1044-5323, (20061001), pages 305 - 317, (20061001), XP024908030 [A] 1-19 * the whole document *
SEARCH- SCHWALLER JUERG ET AL, "Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness", BLOOD, (200701), vol. 109, no. 1, ISSN 0006-4971, pages 331 - 338, XP002557376 [A] 1-19 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents